NeoLight
Medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | $2.8m | Early VC | |
| Total Funding | 000k | ||
Related Content
NeoLight is a babytech company focused on delivering innovative, family-friendly products that empower parents to confidently care for their newborns. Operating in the neonatal medical care market, NeoLight serves parents and healthcare providers by offering advanced phototherapy systems designed for home or bedside use. The company's flagship product, the Skylife Phototherapy System, provides effective jaundice treatment without the need for NICU incubation, thereby keeping families together and reducing hospital readmissions. NeoLight's business model includes offering their phototherapy systems on loan with no commitment for 30 days, allowing parents to use the technology as needed and return it when no longer required. The company generates revenue through the sale and rental of their phototherapy devices, as well as through partnerships with healthcare institutions. NeoLight's technology also includes real-time monitoring features, ensuring accurate interventions and optimal neonatal care.
Keywords: babytech, neonatal care, phototherapy, jaundice treatment, real-time monitoring, family-friendly, healthcare, newborns, NICU alternative, medical devices.